This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Feasibility of Structural Modification of Retinoid X Receptor Agonists to Separate Blood Glucose-Lowering Action from Adverse Effects: Studies in KKA<sup>y</sup> Type 2 Diabetes Model Mice, Biological and Pharmaceutical Bulletin, January 2012, Pharmaceutical Society of Japan,
DOI: 10.1248/bpb.35.629.
You can read the full text:
The following have contributed to this page
